{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:52:35Z","timestamp":1791262355139,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["era4healthcvd-105"],"award-info":[{"award-number":["era4healthcvd-105"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["03-006-2024-0122"],"award-info":[{"award-number":["03-006-2024-0122"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["2018T051"],"award-info":[{"award-number":["2018T051"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["2019T107"],"award-info":[{"award-number":["2019T107"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["2023T138"],"award-info":[{"award-number":["2023T138"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["2019T067"],"award-info":[{"award-number":["2019T067"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"European Innovation Council","doi-asserted-by":"publisher","award":["101115159"],"award-info":[{"award-number":["101115159"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.atherosclerosis.2026.121899","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:09:07Z","timestamp":1788448147000},"page":"121899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice"],"prefix":"10.1016","volume":"421","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9555-0614","authenticated-orcid":false,"given":"Roy P.M.","family":"Snijckers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimke J.","family":"Postel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.C.","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia N.A.","family":"Bernab\u00e9 Kleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilze","family":"Bot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"de Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Foks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7855","key":"10.1016\/j.atherosclerosis.2026.121899_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2026.121899_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1741-7015-11-117","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"11","author":"Frostegard","year":"2013","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121899_bib3","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.atherosclerosis.2015.05.019","article-title":"Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques","volume":"241","author":"Edsfeldt","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.106.147256","article-title":"Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice","volume":"101","author":"Koga","year":"2007","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121899_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.173.1.68","article-title":"T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells that provide help for B cells","volume":"173","author":"Chtanova","year":"2004","journal-title":"J Immunol"},{"issue":"7152","key":"10.1016\/j.atherosclerosis.2026.121899_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121899_bib10","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.4049\/jimmunol.178.5.2827","article-title":"IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production","volume":"178","author":"Coquet","year":"2007","journal-title":"J Immunol"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.121899_bib11","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.200360997","article-title":"Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain","volume":"97","author":"Ozaki","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.immuni.2008.06.001","article-title":"A fundamental role for interleukin-21 in the generation of T follicular helper cells","volume":"29","author":"Vogelzang","year":"2008","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib13","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.4049\/jimmunol.172.4.2048","article-title":"IL-21 induces the functional maturation of murine NK cells","volume":"172","author":"Brady","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","article-title":"IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses","volume":"207","author":"Linterman","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2026.121899_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fimmu.2014.00065","article-title":"Cytokine-Mediated regulation of plasma cell generation: IL-21 takes center stage","volume":"5","author":"Moens","year":"2014","journal-title":"Front Immunol"},{"issue":"5598","key":"10.1016\/j.atherosclerosis.2026.121899_bib17","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121899_bib18","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1182\/blood-2007-09-113050","article-title":"IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy","volume":"111","author":"Hinrichs","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14647","article-title":"IL-21 restricts T follicular regulatory T cell proliferation through Bcl-6 mediated inhibition of responsiveness to IL-2","volume":"8","author":"Jandl","year":"2017","journal-title":"Nat Commun"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.121899_bib20","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1182\/blood-2011-10-388546","article-title":"IL-21 inhibits T cell IL-2 production and impairs treg homeostasis","volume":"119","author":"Attridge","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121899_bib21","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/art.24658","article-title":"A polymorphism within IL21R confers risk for systemic lupus erythematosus","volume":"60","author":"Webb","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.humimm.2010.01.010","article-title":"IL-21 regulates Th17 cells in rheumatoid arthritis","volume":"71","author":"Niu","year":"2010","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib23","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/art.22452","article-title":"Blockade of the interleukin-21\/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis","volume":"56","author":"Young","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121899_bib24","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.178.6.3822","article-title":"IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression","volume":"178","author":"Herber","year":"2007","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121899_bib25","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/apm.12246","article-title":"Effect of serum interleukin 21 on the development of coronary artery disease","volume":"122","author":"Ding","year":"2014","journal-title":"APMIS"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121899_bib26","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/STROKEAHA.107.496703","article-title":"Histological characterization of restenotic carotid plaques in relation to recurrence interval and clinical presentation: a cohort study","volume":"39","author":"Hellings","year":"2008","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121899_bib27","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","article-title":"Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics","volume":"127","author":"Depuydt","year":"2020","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.121899_bib28","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/cvr\/cvad099","article-title":"Single-cell profiling reveals age-associated immunity in atherosclerosis","volume":"119","author":"Smit","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121899_bib29","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.117.312509","article-title":"Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis","volume":"122","author":"Cochain","year":"2018","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.avsg.2013.08.016","article-title":"Carotid endarterectomy national trends over a decade: does sex matter?","volume":"28","author":"Kuy","year":"2014","journal-title":"Ann Vasc Surg"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12979-024-00434-3","article-title":"Sexual dimorphism in atherosclerotic plaques of aged Ldlr(-\/-) mice","volume":"21","author":"Smit","year":"2024","journal-title":"Immun Ageing"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121899_bib32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.18632\/aging.100490","article-title":"Increased IL-21 secretion by aged CD4+T cells is associated with prolonged STAT-4 activation and CMV seropositivity","volume":"4","author":"Agrawal","year":"2012","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12979-025-00510-2","article-title":"Chronic IL-21 drives neuroinflammation and promotes lipid accumulation in microglia","volume":"22","author":"Oyamada","year":"2025","journal-title":"Immun Ageing"},{"key":"10.1016\/j.atherosclerosis.2026.121899_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4933-11-12","article-title":"The effect of aging on the frequency, phenotype and cytokine production of human blood CD4 + CXCR5 + T follicular helper cells: comparison of aged and young subjects","volume":"11","author":"Zhou","year":"2014","journal-title":"Immun Ageing"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib36","first-page":"295","article-title":"B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells","volume":"116","author":"Douna","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2026.121899_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.740531","article-title":"Stimulation of the PD-1 pathway decreases atherosclerotic lesion development in Ldlr deficient mice","volume":"8","author":"Grievink","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"10289","key":"10.1016\/j.atherosclerosis.2026.121899_bib38","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121899_bib39","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/eji.201142317","article-title":"Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability","volume":"42","author":"Lee","year":"2012","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib40","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.4049\/jimmunol.173.4.2227","article-title":"Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment","volume":"173","author":"Polanczyk","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/eji.202048658","article-title":"Human pregnancy levels of estrogen and progesterone contribute to humoral immunity by activating T(FH)\/B cell axis","volume":"51","author":"Monteiro","year":"2021","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121899_bib42","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2337\/db11-0880","article-title":"IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response","volume":"60","author":"Petrelli","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2026.121899_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661580","article-title":"IL-21 Receptor Blockade Shifts the Follicular T Cell Balance and Reduces De Novo Donor-Specific Antibody Generation","volume":"12","author":"Nian","year":"2021","journal-title":"Front Immunol"},{"issue":"26","key":"10.1016\/j.atherosclerosis.2026.121899_bib44","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation","volume":"114","author":"Bucher","year":"2009","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.atherosclerosis.2026.121899_bib45","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1073\/pnas.1511711112","article-title":"Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells","volume":"112","author":"Wan","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2012.05.027","article-title":"STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease","volume":"37","author":"Laurence","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121899_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.immuni.2010.09.001","article-title":"Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I","volume":"33","author":"Xu","year":"2010","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2013.06.014","article-title":"Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells","volume":"230","author":"Dietel","year":"2013","journal-title":"Atherosclerosis"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.121899_bib49","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","article-title":"Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes","volume":"27","author":"Mor","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2014.10.088","article-title":"Treg\/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis","volume":"238","author":"Potekhina","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4049\/jimmunol.182.1.148","article-title":"Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation","volume":"182","author":"Chauhan","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121899_bib52","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI63891","article-title":"Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis","volume":"123","author":"Klingenberg","year":"2013","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib53","first-page":"154","article-title":"Effects of FOXP3 on the progression of atherosclerosis plaque in ApoE-knock out mice","volume":"27","author":"Wang","year":"2011","journal-title":"Chinese Journal of Cellular and Molecular Immunology"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib54","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2011.04.029","article-title":"Differential effects of regulatory T cells on the initiation and regression of atherosclerosis","volume":"218","author":"Foks","year":"2011","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib56","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41591-025-04090-y","article-title":"Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial","volume":"32","author":"Sriranjan-Rothwell","year":"2026","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/ATVBAHA.114.303568","article-title":"Treating atherosclerosis with regulatory T cells","volume":"35","author":"Foks","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib58","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0008-6363(00)00287-X","article-title":"Effects of interleukin-10 on monocyte\/endothelial cell adhesion and MMP-9\/TIMP-1 secretion","volume":"49","author":"Mostafa Mtairag","year":"2001","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121899_bib59","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1194\/jlr.D000497","article-title":"The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation","volume":"51","author":"Lin","year":"2010","journal-title":"J Lipid Res"},{"issue":"6116","key":"10.1016\/j.atherosclerosis.2026.121899_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121899_bib61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2026.121899_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cellimm.2019.02.002","article-title":"Biological activities of interleukin (IL)-21 in human monocytes and macrophages","volume":"337","author":"Vallieres","year":"2019","journal-title":"Cell Immunol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121899_bib63","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.1201941","article-title":"IL-21 enhances phagocytosis in mononuclear phagocyte cells: identification of spleen tyrosine kinase as a novel molecular target of IL-21","volume":"190","author":"Valli\u00e8res","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121899_bib64","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.4049\/jimmunol.1402603","article-title":"Intratumoral delivery of IL-21 overcomes anti-Her2\/Neu resistance through shifting tumor-associated macrophages from M2 to M1 phenotype","volume":"194","author":"Xu","year":"2015","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib65","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4049\/jimmunol.2000206","article-title":"CD11c(+) T-bet(+) B cells require IL-21 and IFN-gamma from type 1 T follicular helper cells and intrinsic Bcl-6 expression but develop normally in the absence of T-bet","volume":"205","author":"Levack","year":"2020","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121899_bib66","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","article-title":"IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121899_bib67","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.RES.0000018941.10726.FA","article-title":"Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes","volume":"90","author":"Pinderski","year":"2002","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121899_bib68","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ Res"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2026.121899_bib69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF03402102","article-title":"Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice","volume":"9","author":"Caligiuri","year":"2003","journal-title":"Mol Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.20091777","article-title":"IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism","volume":"207","author":"Zotos","year":"2010","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4049\/jimmunol.0903207","article-title":"IL-21 receptor is critical for the development of memory B cell responses","volume":"186","author":"Rankin","year":"2011","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121899_bib72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20111229","article-title":"Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome","volume":"210","author":"Kotlarz","year":"2013","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121899_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5414\/CP202474","article-title":"Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial","volume":"54","author":"Ignatenko","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121899_bib74","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/cts.12715","article-title":"A double-blind, phase I, single ascending dose study to assess the safety, pharmacokinetics, and pharmacodynamics of BOS161721 in healthy subjects","volume":"13","author":"Hussaini","year":"2020","journal-title":"Clin Transl Sci"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:18:46Z","timestamp":1791260326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026012657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":74,"alternative-id":["S0021915026012657"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121899","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121899"}}